BiotechTube
Elucent Medical

Elucent Medical

Minneapolis, United States· Est.
elucent.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Elucent Medical, founded in 2015 and based in Minneapolis, is pioneering a new standard in surgical oncology with its EnVisio System. The technology platform integrates an implantable SmartClip marker, an attachable SmartSensor, and a SmartSurface field generator to deliver continuous, true 3D surgical awareness, aiming to improve the precision of tumor removal. The company is commercializing its system for soft tissue localization, initially in breast cancer surgery, with endorsements from key surgical centers. As a private, likely venture-backed firm, Elucent is positioned in the high-growth surgical guidance market but faces competition and the challenge of driving widespread clinical adoption.

Oncology

Technology Platform

In-Body Spatial Intelligence™ (iSi) platform, comprising the EnVisio System with implantable SmartClip markers, attachable SmartSensor for instruments, and SmartSurface field generator. It provides real-time, continuous 3D surgical navigation and tracking for soft tissue localization.

Opportunities

The global shift towards value-based care and minimally invasive surgery drives demand for technologies that improve precision and efficiency.
Elucent's platform is adaptable beyond breast surgery to numerous other soft tissue oncology procedures, representing a significant expansion opportunity.
The system's integration capability with existing instruments lowers the barrier to adoption compared to fully robotic systems.

Risk Factors

Intense competition from established and emerging wire-free localization technologies poses a significant market penetration risk.
Achieving widespread hospital adoption requires demonstrating clear cost-effectiveness and superior clinical outcomes, which demands substantial commercial investment and time.
Technological evolution in intraoperative imaging could potentially disrupt the need for a separate localization platform.

Competitive Landscape

Elucent competes in the wire-free breast lesion localization market against companies like Hologic (SAVI Scout), Merit Medical (LOCalizer), and BD (Bard). It differentiates by offering real-time 3D navigation rather than simple proximity detection. Broader competition includes surgical navigation giants like Medtronic and Stryker, though they are historically focused on hard tissue (ortho, spine, neuro).

More companies in Diagnostics & Precision Medicine →More companies in United States →